Crescent Biopharma Inc banner

Wall St Price Targets

C68 Price Forecast
Based on 9 analysts

+109% Upside
from €10.6 today

Crescent Biopharma Inc (C68)’s 12-month stock price forecast through November 2027 has a consensus target of €22.14, implying 109% upside. The forecast is based on price targets from 9 Wall Street analysts.

C68 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for C68 yet.

Crescent Biopharma Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is C68's stock price target?
Price Target
22.14 EUR

According to Wall Street analysts, the average 1-year price target for C68 is 22.14 EUR with a low forecast of 18.79 EUR and a high forecast of 26.04 EUR.

What is the Revenue forecast for Crescent Biopharma Inc?
Projected CAGR
72%

Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 8 years is 72%.

Back to Top